Combinatorial biosynthesis of plant-specific coumarins in bacteria (Q46380762)

21 December 2017

title

Combinatorial biosynthesis of plant-specific coumarins in bacteria (English)

1 reference

21 December 2017

1 reference

21 December 2017

author name string

Xinxiao Sun

series ordinal

1 reference

21 December 2017

Qipeng Yuan

series ordinal

1 reference

21 December 2017

Yajun Yan

series ordinal

1 reference

21 December 2017

publication date

30 April 2013

1 reference

21 December 2017

published in

Metabolic Engineering

1 reference

21 December 2017

volume

1 reference

21 December 2017

page(s)

69-77

1 reference

21 December 2017

Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Biosynthesis: is it time to go retro?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Drug discovery from medicinal plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

The role of natural product chemistry in drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products to drugs: natural product-derived compounds in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Metabolic engineering for plant natural product biosynthesis in microbes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Drug discovery from natural sources.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products in drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Three 4-coumarate:coenzyme A ligases in Arabidopsis thaliana represent two evolutionarily divergent classes in angiosperms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Improving lycopene production in Escherichia coli by engineering metabolic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products: sources and databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

The 2-hydroxylation of trans-cinnamic acid by chloroplasts from Melilotus alba Desr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Enzymatic assembly of DNA molecules up to several hundred kilobases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Light-Induced Trans to Cis Conversion of beta-d-Glucosyl o-Hydroxycinnamic Acid in Melilotus alba Leaves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Facile production of minor metabolites for drug development using a CYP3A shuffled library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Scopoletin is biosynthesized via ortho-hydroxylation of feruloyl CoA by a 2-oxoglutarate-dependent dioxygenase in Arabidopsis thaliana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Metabolic engineering for drug discovery and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Antiinflammatory and antioxidant evaluation of novel coumarin derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

High-Yield Resveratrol Production in Engineered Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Molecular cloning and functional analysis of the ortho-hydroxylases of p-coumaroyl coenzyme A/feruloyl coenzyme A involved in formation of umbelliferone and scopoletin in sweet potato, Ipomoea batatas (L.) Lam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Plant natural products: back to the future or into extinction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Microbial production of plant benzylisoquinoline alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products from synthetic biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

A review of coumarin derivatives in pharmacotherapy of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

A bacterial platform for fermentative production of plant alkaloids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products as sources of new drugs over the last 25 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

The influence of natural products upon drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Natural products as sources of new drugs over the period 1981-2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Subcellular Localization of 2-(beta-d-Glucosyloxy)-Cinnamic Acids and the Related beta-glucosidase in Leaves of Melilotus alba Desr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Chemistry. The renaissance of natural products as drug candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Intracellular Localization of Two Enzymes Involved in Coumarin Biosynthesis in Melilotus alba.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Targeted proteomics for metabolic pathway optimization: application to terpene production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Optimization of a heterologous pathway for the production of flavonoids from glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Metabolic engineering of Escherichia coli for 1-butanol and 1-propanol production via the keto-acid pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Treatment with coumarin to prevent or delay recurrence of malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

A 2-oxoglutarate-dependent dioxygenase from Ruta graveolens L. exhibits p-coumaroyl CoA 2'-hydroxylase activity (C2'H): a missing step in the synthesis of umbelliferone in plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Metabolic engineering of anthocyanin biosynthesis in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Biosynthesis of natural flavanones in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Biosynthesis of 5-deoxyflavanones in microorganisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

High-yield anthocyanin biosynthesis in engineered Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

Engineering natural products using combinatorial biosynthesis and biocatalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.04.004

10.1016/J.YMBEN.2013.04.004

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017